Patent strengthens IP foundation supporting a minimally invasive platform designed to expand access to circulatory support across a broader patient population This patent reinforces our commitment to ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results